The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Intestinal Neoplasms

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Intestinal Neoplasms


Psychiatry related information on Intestinal Neoplasms


High impact information on Intestinal Neoplasms

  • As Mbd2-deficient mice are viable and fertile, their resistance to intestinal cancer may be of therapeutic relevance [7].
  • The Min mouse strain, in which the ApcMin mutation disrupts the mouse homologue of the human familial polyposis gene, develops intestinal neoplasms whose multiplicity is strongly affected by genetic background [8].
  • In a pedigree derived from a mouse treated with the mutagen ethylnitrosourea, a mutation has been identified that predisposes to spontaneous intestinal cancer [9].
  • Here we provide evidence that there may be a direct link between inhibition of intestinal cancer growth and selective inhibition of the COX-2 pathway [10].
  • Combined inhibitors of carcinogenesis: effect on azoxymethane-induced intestinal cancer in rats [11].

Chemical compound and disease context of Intestinal Neoplasms


Biological context of Intestinal Neoplasms


Anatomical context of Intestinal Neoplasms


Gene context of Intestinal Neoplasms


Analytical, diagnostic and therapeutic context of Intestinal Neoplasms


  1. Effect of Lactobacillus acidophilus dietary supplements on 1,2-dimethylhydrazine dihydrochloride-induced intestinal cancer in rats. Goldin, B.R., Gorbach, S.L. J. Natl. Cancer Inst. (1980) [Pubmed]
  2. Quercetin, a rat intestinal and bladder carcinogen present in bracken fern (Pteridium aquilinum). Pamukcu, A.M., Yalçiner, S., Hatcher, J.F., Bryan, G.T. Cancer Res. (1980) [Pubmed]
  3. Genistein attenuates peritoneal metastasis of azoxymethane-induced intestinal adenocarcinomas in Wistar rats. Iishi, H., Tatsuta, M., Baba, M., Yano, H., Sakai, N., Akedo, H. Int. J. Cancer (2000) [Pubmed]
  4. Neoplastic and pre-neoplastic changes in gastrointestinal endometriosis: a study of 17 cases. Yantiss, R.K., Clement, P.B., Young, R.H. Am. J. Surg. Pathol. (2000) [Pubmed]
  5. Relationship between intracellular ROS production and membrane mobility in curcumin- and tetrahydrocurcumin-treated human gingival fibroblasts and human submandibular gland carcinoma cells. Atsumi, T., Fujisawa, S., Tonosaki, K. Oral diseases. (2005) [Pubmed]
  6. Dietary habits and gastro-intestinal cancers: a comparative case-control study of stomach and large intestinal cancers in Nagoya, Japan. Tajima, K., Tominaga, S. Jpn. J. Cancer Res. (1985) [Pubmed]
  7. Deficiency of Mbd2 suppresses intestinal tumorigenesis. Sansom, O.J., Berger, J., Bishop, S.M., Hendrich, B., Bird, A., Clarke, A.R. Nat. Genet. (2003) [Pubmed]
  8. Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis. Cormier, R.T., Hong, K.H., Halberg, R.B., Hawkins, T.L., Richardson, P., Mulherkar, R., Dove, W.F., Lander, E.S. Nat. Genet. (1997) [Pubmed]
  9. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Moser, A.R., Pitot, H.C., Dove, W.F. Science (1990) [Pubmed]
  10. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. Sheng, H., Shao, J., Kirkland, S.C., Isakson, P., Coffey, R.J., Morrow, J., Beauchamp, R.D., DuBois, R.N. J. Clin. Invest. (1997) [Pubmed]
  11. Combined inhibitors of carcinogenesis: effect on azoxymethane-induced intestinal cancer in rats. Nigro, N.D., Bull, A.W., Wilson, P.S., Soullier, B.K., Alousi, M.A. J. Natl. Cancer Inst. (1982) [Pubmed]
  12. Combination of a poxvirus-based vaccine with a cyclooxygenase-2 inhibitor (celecoxib) elicits antitumor immunity and long-term survival in CEA.Tg/MIN mice. Zeytin, H.E., Patel, A.C., Rogers, C.J., Canter, D., Hursting, S.D., Schlom, J., Greiner, J.W. Cancer Res. (2004) [Pubmed]
  13. Inhibition of intestinal tumorigenesis in Apcmin/+ mice by (-)-epigallocatechin-3-gallate, the major catechin in green tea. Ju, J., Hong, J., Zhou, J.N., Pan, Z., Bose, M., Liao, J., Yang, G.Y., Liu, Y.Y., Hou, Z., Lin, Y., Ma, J., Shih, W.J., Carothers, A.M., Yang, C.S. Cancer Res. (2005) [Pubmed]
  14. Natural history of intestinal neoplasms induced in rats by a single injection of methyl(acetoxymethyl)nitrosamine. Ward, J.M., Rice, J.M., Roller, P.P., Wenk, M.L. Cancer Res. (1977) [Pubmed]
  15. Suppression of large intestinal cancer in F344 rats by inositol hexaphosphate. Shamsuddin, A.M., Elsayed, A.M., Ullah, A. Carcinogenesis (1988) [Pubmed]
  16. Dairy proteins protect against dimethylhydrazine-induced intestinal cancers in rats. McIntosh, G.H., Regester, G.O., Le Leu, R.K., Royle, P.J., Smithers, G.W. J. Nutr. (1995) [Pubmed]
  17. Cloning and characterization of the human activity-dependent neuroprotective protein. Zamostiano, R., Pinhasov, A., Gelber, E., Steingart, R.A., Seroussi, E., Giladi, E., Bassan, M., Wollman, Y., Eyre, H.J., Mulley, J.C., Brenneman, D.E., Gozes, I. J. Biol. Chem. (2001) [Pubmed]
  18. Genetic pattern, histological structure, and cellular phenotype in early and advanced gastric cancers: evidence for structure-related genetic subsets and for loss of glandular structure during progression of some tumors. Luinetti, O., Fiocca, R., Villani, L., Alberizzi, P., Ranzani, G.N., Solcia, E. Hum. Pathol. (1998) [Pubmed]
  19. Stem cell kinetics and intestinal cancer. Morris, J.A. Anticancer Res. (1994) [Pubmed]
  20. Proinflammatory cytokines trigger MUC gene expression and mucin release in the intestinal cancer cell line LS180. Enss, M.L., Cornberg, M., Wagner, S., Gebert, A., Henrichs, M., Eisenblätter, R., Beil, W., Kownatzki, R., Hedrich, H.J. Inflamm. Res. (2000) [Pubmed]
  21. Cloning and functional characterization of the human VIP1/PACAP receptor promoter. Couvineau, A., Maoret, J.J., Rouyer-Fessard, C., Carrero, I., Laburthe, M. Ann. N. Y. Acad. Sci. (1998) [Pubmed]
  22. A fish oil derived concentrate enriched in eicosapentaenoic and docosahexaenoic acid as ethyl ester suppresses the formation and growth of intestinal polyps in the Min mouse. Paulsen, J.E., Elvsaas, I.K., Steffensen, I.L., Alexander, J. Carcinogenesis (1997) [Pubmed]
  23. The influence of fixation delay on mitotic activity and flow cytometric cell cycle variables. Bergers, E., Jannink, I., van Diest, P.I., Cuesta, M.A., Meyer, S., van Mourik, J.C., Baak, J.P. Hum. Pathol. (1997) [Pubmed]
  24. Identification of hereditary nonpolyposis colorectal cancer in the general population. The 6-year experience of a population-based registry. Ponz de Leon, M., Sassatelli, R., Benatti, P., Roncucci, L. Cancer (1993) [Pubmed]
  25. Small intestinal cancer with extensive lymph node metastases showing complete remission by methotrexate/5-fluorouracil sequential therapy: report of a case. Onodera, H., Nishitai, R., Shimizu, K., Maetani, S., Imamura, M. Surgery today. (1997) [Pubmed]
  26. Different mutator phenotypes in Mlh1- versus Pms2-deficient mice. Yao, X., Buermeyer, A.B., Narayanan, L., Tran, D., Baker, S.M., Prolla, T.A., Glazer, P.M., Liskay, R.M., Arnheim, N. Proc. Natl. Acad. Sci. U.S.A. (1999) [Pubmed]
  27. Epiregulin is not essential for development of intestinal tumors but is required for protection from intestinal damage. Lee, D., Pearsall, R.S., Das, S., Dey, S.K., Godfrey, V.L., Threadgill, D.W. Mol. Cell. Biol. (2004) [Pubmed]
  28. Bacteria-induced intestinal cancer in mice with disrupted Gpx1 and Gpx2 genes. Chu, F.F., Esworthy, R.S., Chu, P.G., Longmate, J.A., Huycke, M.M., Wilczynski, S., Doroshow, J.H. Cancer Res. (2004) [Pubmed]
  29. Smad4 haploinsufficiency in mouse models for intestinal cancer. Alberici, P., Jagmohan-Changur, S., De Pater, E., Van Der Valk, M., Smits, R., Hohenstein, P., Fodde, R. Oncogene (2006) [Pubmed]
  30. Expression of chemokine receptors in human gastric cancer. Kwak, M.K., Hur, K., Park, d.o. .J., Lee, H.J., Lee, H.S., Kim, W.H., Lee, K.U., Choe, K.J., Yang, H.K. Tumour Biol. (2005) [Pubmed]
  31. Effect of germanium on 1,2-dimethylhydrazine-induced intestinal cancer in rats. Jao, S.W., Lee, W., Ho, Y.S. Dis. Colon Rectum (1990) [Pubmed]
WikiGenes - Universities